Effectiveness and Safety of Lenvatinib Combined With Chinese Herbal Medicine for Patients With Unresectable Hepatocellular Carcinoma: A Real-world Study in China

CompletedOBSERVATIONAL
Enrollment

142

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Unresectable Hepatocellular Carcinoma
Interventions
DRUG

Chinese Herbal Medicine

Patients were treated with Chinese herbal medicine (CHM). CHM refers to the administration of a syndrome-specific herbal formula prescribed by a Traditional Chinese Medicine (TCM) physician after an uHCC diagnosis. Physicians determine the formula based on tongue and pulse examinations and personalized TCM syndromes derived from individual patient symptoms, adhering to established therapeutic principles and long-term clinical experience of physicians. The CHM formula applied in the study followed overarching TCM strategies, including reinforcing spleen qi, harmonizing liver qi, addressing blood stasis, and detoxification.

Trial Locations (1)

510407

the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou

All Listed Sponsors
lead

Guangzhou University of Chinese Medicine

OTHER

NCT06315101 - Effectiveness and Safety of Lenvatinib Combined With Chinese Herbal Medicine for Patients With Unresectable Hepatocellular Carcinoma: A Real-world Study in China | Biotech Hunter | Biotech Hunter